The Exchange had sought clarification from IOL Chemicals and Pharmaceuticals Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013 or as per Indian Accounting Standard The response of the Company is enclosed.
IOLCP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The stock exchange asked IOL Chemicals and Pharmaceuticals to clarify its financial results for the quarter ended 30 June 2025 under SEBI Listing Regulations. The exchange pointed out that the submitted results were not in the format prescribed under Schedule III of the Companies Act, 2013 or Indian Accounting Standards. The company has submitted its response to the exchange. No details of the response or any further exchange action have been disclosed yet.
This appears to be a procedural compliance query about how the financials were formatted rather than a penalty or investigation. Investors should watch for any follow-up notice from the exchange, but there is no immediate indication of financial misstatement or enforcement action against the company.